Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.62 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362811 | 1.00 | ATM (0.62) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL13139659 | 0.88 | TRPA1 (0.73) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL29113726 | 0.88 | ALDH1A1 (0.50) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL930935 | 0.86 | TRPA1 (0.54) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL5589909 | 0.84 | TRPA1 (0.60) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL27572785 | 0.84 | ATM (0.48) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL674991 | 0.84 | ALDH1A1 (0.67) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL758202 | 0.83 | HPGD (0.52) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL31337248 | 0.83 | HPGD (0.52) | ATMTRPA1GAAMGAMSI | |
| SCHEMBL31069812 | 0.83 | TRPA1 (0.58) | ATMTRPA1GAAMGAMSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1494995-A1 | 3-AMINOPHENOL DERIVATIVES SUBSTITUTED IN THE 2-POSITION, AND DYES CONTAINING THESE COMPOUNDS | Wella Aktiengesellschaft (DE) | 2005-01-12 | — | — | EP | claimed |
| WO-2003087034-A1 | 3-AMINOPHENOL DERIVATIVES SUBSTITUTED IN THE 2-POSITION, AND DYES CONTAINING THESE COMPOUNDS | WELLA AKTIENGESELLSCHAFT (DE) | 2003-10-23 | — | — | WO | claimed |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2025-12-23 | — | — | US | disclosed |
| CN-119948080-A | Active ester resin, epoxy resin composition, cured product thereof, prepreg, laminated board and laminated film | 日铁化学材料株式会社 | 2025-05-06 | — | — | CN | disclosed |
| CN-119403857-A | Multifunctional vinyl resin and method for producing same | 日铁化学材料株式会社 | 2025-02-07 | — | — | CN | disclosed |
| CN-118599090-A | Vinyl resin production method, vinyl resin, composition thereof, cured product, prepreg, resin sheet, and laminate | 日铁化学材料株式会社 | 2024-09-06 | — | — | CN | disclosed |
| WO-2024106209-A1 | POLYFUNCTIONAL VINYL RESIN, MANUFACTURING METHOD THEREFOR, POLYFUNCTIONAL VINYL RESIN COMPOSITION, AND CURED PRODUCT THEREOF | 日鉄ケミカル＆マテリアル株式会社 | 2024-05-23 | — | — | WO | disclosed |
| WO-2024071129-A1 | ACTIVE ESTER RESIN, EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, PREPREG, LAMINATED BOARD, AND BUILD-UP FILM | 日鉄ケミカル＆マテリアル株式会社 | 2024-04-04 | — | — | WO | disclosed |
| CN-108779190-B | Anaerobically curable resin composition | 三键有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-113956292-B | Mitochondrial targeting compound with aggregation-induced emission property and synthesis method and application thereof | 南京师范大学 | 2023-10-27 | — | — | CN | disclosed |
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| US-4122235-A | LAMINATE, METAL SALT CURING ACCELERATOR | MONSANTO COMPANY (US) | 1978-10-24 | — | — | US | disclosed |
| US-4120847-A | High ortho etherified resole resins | MONSANTO COMPANY (US) | 1978-10-17 | — | — | US | disclosed |
| US-4112188-A | LAMINATE, BORIC ACID, DIAMMONIUM TETRABORATE, DIAMMONIUM PENTABORATE, AND/OR DIAMMONIUM OCTABORATE AS ACCELERATORS | MONSANTO COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4045398-A | BORON COMPOUND CURING ACCELERATOR | MONSANTO COMPANY (US) | 1977-08-30 | — | — | US | disclosed |
| US-4043970-A | IMPROVED CURE RATE IN ELECTRICAL LAMINATES | MONSANTO COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
| US-4022942-A | NOVOLAKS OR B-STAGE RESINS | MONSANTO COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
| US-3974229-A | ALKYLATION CATALYSTS | GENERAL ELECTRIC COMPANY (US) | 1976-08-10 | — | — | US | disclosed |
| US-3972836-A | MAGNESIUM OXIDE-MANGANESE OXIDE CATALYST | GENERAL ELECTRIC COMPANY (US) | 1976-08-03 | — | — | US | disclosed |
| US-3937669-A | VANADIUM OXIDE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | PFAS, PHOSPHO1, PAF1 | ATM 2797/4885TRPA1 1153/4885GAA 4492/4885 |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | PFAS, PHOSPHO1, PAF1 | ATM 2797/4885TRPA1 1153/4885GAA 4492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.